Feb232026

Brensocatib licensed as the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis in patients 12 years and older

image_pdfimage_print

As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.